Methohexital is an ultra-short acting methylated oxybarbiturate anesthetic agent. It is about twice as potent as thiopental and has a duration of action about H as long. Like all the barbiturates, methohexital acts by depressing the reticular activating center of the brain.
Indicated for lymphomas and some solid tumors in dogs and cats (see the Doses section and the recommended treatment protocol references at the end of this section). In human medicine, methotrexate is also being used to treat refractory rheumatoid arthritis and severe psoriasis.
劑量數字暫停提供：VetPro 的劑量改依 DRUGAPI 藥物資料庫對外的內容，DRUGAPI 目前不提供可直接計算的劑量。下方列出 DRUGAPI 的審查結論與劑量審查引用的來源；計算機可手動輸入劑量換算。
25 張歷史、法規、研究與比較數值卡全部 non-executable。live 犬貓原文含損壞分數字形並截斷，卻另有不一致的犬貓結構範圍、未鎖產品的多物種範圍及無效物種 note；山羊歷史高值前用藥方案也缺乏現行精確產品與完整 protocol gate。若未同時確認精確 thiopental sodium 產品、復溶濃度、物種、IV 途徑、適應症、前用藥／合併麻醉藥、注射速率、法域、氣道、供氧、正壓通氣、復甦與持續監測，禁止計算或產生處方。
DRUGAPI 劑量審查引用的獸醫官方標示（各標示只適用於其產品、物種與法域，不可互換）
依出現頻率分組；嚴重副作用獨立列出，臨床上需立即辨識。